In this article, Dr Duaa Saeed-Chesterman explains the development of the NHS Cervical Screening Programme, highlighting its success in reducing cervical cancer rates through human papillomavirus (HPV) testing and vaccination, and outlines plans to harness emerging technologies like molecular triage and digital pathology to work towards NHS England’s target of eradicating cervical cancer by 2040.
Also of interest
-
Guidelines on staffing and workload for histopathology and cytopathology departments, 4th edition
This is the most recent version of this document. However, it is currently in the process of being reviewed and updated. We do not yet have a known publication date for the updated version.